- Home
- TREE vs EVMN Comparison
TREE vs EVMN Comparison
Compare TREE & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TREE | EVMN |
|---|---|---|
| Founded | 1996 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 693.0M | 628.9M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | TREE | EVMN |
|---|---|---|
| Price | $52.75 | $17.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $72.50 | $39.33 |
| AVG Volume (30 Days) | 147.7K | ★ 208.2K |
| Earning Date | 10-30-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $1,059,158,000.00 | $13,000,000.00 |
| Revenue This Year | $22.86 | $89.43 |
| Revenue Next Year | $7.32 | N/A |
| P/E Ratio | $51.44 | ★ N/A |
| Revenue Growth | 37.01 | ★ 160.00 |
| 52 Week Low | $33.50 | $13.89 |
| 52 Week High | $77.35 | $24.03 |
Technical Indicators
Market Signals| Indicator | TREE | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 45.23 | N/A |
| Support Level | $50.00 | N/A |
| Resistance Level | $55.00 | N/A |
| Average True Range (ATR) | 1.93 | 0.00 |
| MACD | 0.13 | 0.00 |
| Stochastic Oscillator | 37.10 | 0.00 |
Price Performance
Historical ComparisonAbout TREE LendingTree Inc.
LendingTree Inc. is a U.S.-based company that mainly operates an online loan marketplace. The company offers online tools and resources to help consumers find loans or other credit-based products, including mortgage loans, reverse mortgages, home equity loans, personal loans, auto loans, credit cards, student loans, small business loans, and various related products. It provides consumers with direct access to a wide array of lenders. The company has three reportable segments: Home, Consumer, and Insurance. It generates match fees by connecting consumers with lenders and closing fees from lenders when a transaction is finalized. The company conducts business solely in the United States.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.